|
 |
|
|||||||
|
|||||||||
© 2002 by the American Diabetes Association, Inc.
Hypoglycemia-Associated Autonomic Failure in Advanced Type 2 Diabetes
From the Division of Endocrinology, Diabetes and Metabolism, and the General Clinical Research Center and the Diabetes Research and Training Center, Washington University School of Medicine, St. Louis, Missouri
We tested the hypotheses that the glucagon response to hypoglycemia is reduced in patients who are approaching the insulin-deficient end of the spectrum of type 2 diabetes and that recent antecedent hypoglycemia shifts the glycemic thresholds for autonomic (including adrenomedullary epinephrine) and symptomatic responses to hypoglycemia to lower plasma glucose concentrations in type 2 diabetes. Hyperinsulinemic stepped hypoglycemic clamps (85, 75, 65, 55, and 45 mg/dl steps) were performed on two consecutive days, with an additional 2 h of hypoglycemia (50 mg/dl) in the afternoon of the first day, in 13 patients with type 2 diabetes—7 treated with oral hypoglycemic agents (OHA RX; mean [±SD] HbA1c 8.6 ± 1.1%) and 6 requiring therapy with insulin for an average of 5 years and with reduced C-peptide levels (insulin RX, HbA1c 7.5 ± 0.7%)—and 15 nondiabetic control subjects. The glucagon response to hypoglycemia was virtually absent (P = 0.0252) in the insulin-deficient type 2 diabetic patients (insulin RX mean [±SE] final values of 52 ± 16 vs. 93 ± 15 pg/ml in control subjects and 98 ± 16 pg/ml in type 2 diabetic patients, OHA RX on day 1). Glucagon (P = 0.0015), epinephrine (P = 0.0002), and norepinephrine (P = 0.0138) responses and neurogenic (P = 0.0149) and neuroglycopenic (P = 0.0015) symptom responses to hypoglycemia were reduced on day 2 after hypoglycemia on day 1 in type 2 diabetic patients; these responses were not eliminated, but their glycemic thresholds were shifted to lower plasma glucose concentrations. In addition, the glycemic thresholds for these responses were at higher-than-normal plasma glucose concentrations (P = 0.0082, 0.0028, 0.0023, and 0.0182, respectively) at baseline (day 1) in OHA RX type 2 diabetic patients, with relatively poorly controlled diabetes. Because the glucagon response to falling plasma glucose levels is virtually absent and the glycemic thresholds for autonomic and symptomatic responses to hypoglycemia are shifted to lower glucose concentrations by recent antecedent hypoglycemia, patients with advanced type 2 diabetes, like those with type 1 diabetes, are at risk for hypoglycemia-associated autonomic failure and the resultant vicious cycle of recurrent iatrogenic hypoglycemia.
CiteULike 
Del.icio.us 
Digg 
Reddit 
Technorati What's this?
This article has been cited by other articles:
|
|
 |
|
  O. Chan, H. Cheng, R. Herzog, D. Czyzyk, W. Zhu, A. Wang, R. J. McCrimmon, M. R. Seashore, and R. S. Sherwin Increased GABAergic Tone in the Ventromedial Hypothalamus Contributes to Suppression of Counterregulatory Reponses After Antecedent Hypoglycemia Diabetes, May 1, 2008; 57(5): 1363 - 1370. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. M. Arbelaez, W. J. Powers, T. O. Videen, J. L. Price, and P. E. Cryer Attenuation of Counterregulatory Responses to Recurrent Hypoglycemia by Active Thalamic Inhibition: A Mechanism for Hypoglycemia-Associated Autonomic Failure Diabetes, February 1, 2008; 57(2): 470 - 475. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. J. Cox, L. Gonder-Frederick, L. Ritterband, W. Clarke, and B. P. Kovatchev Prediction of Severe Hypoglycemia Diabetes Care, June 1, 2007; 30(6): 1370 - 1373. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. R. White Jr. The Contribution of Medications to Hypoglycemia Unawareness Diabetes Spectr, April 1, 2007; 20(2): 77 - 80. [Full Text] [PDF]
|
|
|
|
|
|
P. E. Cryer Management of Hyperglycemia in Type 2 Diabetes: A Consensus Algorithm for the Initiation and Adjustment of Therapy: A Consensus Statement From the American Diabetes Association and the European Association for the Study of Diabetes: Response to Nathan et al. Diabetes Care, January 1, 2007; 30(1): 190 - 192. [Full Text] [PDF]
|
|
|
|
|
|
N. M. Sanders, G. J. Taborsky Jr., C. W. Wilkinson, W. Daumen, and D. P. Figlewicz Antecedent Hindbrain Glucoprivation Does Not Impair the Counterregulatory Response to Hypoglycemia Diabetes, January 1, 2007; 56(1): 217 - 223. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 V. J. Briscoe and S. N. Davis Hypoglycemia in Type 1 and Type 2 Diabetes: Physiology, Pathophysiology, and Management Clin. Diabetes, July 1, 2006; 24(3): 115 - 121. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. J. Meier, L. L. Kjems, J. D. Veldhuis, P. Lefebvre, and P. C. Butler Postprandial suppression of glucagon secretion depends on intact pulsatile insulin secretion: further evidence for the intraislet insulin hypothesis. Diabetes, April 1, 2006; 55(4): 1051 - 1056. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. N. Zammitt and B. M. Frier Hypoglycemia in Type 2 Diabetes: Pathophysiology, frequency, and effects of different treatment modalities Diabetes Care, December 1, 2005; 28(12): 2948 - 2961. [Full Text] [PDF]
|
|
|
|
|
|
P. E. Cryer Mechanisms of Hypoglycemia-Associated Autonomic Failure and Its Component Syndromes in Diabetes Diabetes, December 1, 2005; 54(12): 3592 - 3601. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Z. Israelian, N. R. Gosmanov, E. Szoke, M. Schorr, S. Bokhari, P. E. Cryer, J. E. Gerich, and C. Meyer Increasing the Decrement in Insulin Secretion Improves Glucagon Responses to Hypoglycemia in Advanced Type 2 Diabetes Diabetes Care, November 1, 2005; 28(11): 2691 - 2696. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Diao, Z. Asghar, C. B. Chan, and M. B. Wheeler Glucose-regulated Glucagon Secretion Requires Insulin Receptor Expression in Pancreatic {alpha}-Cells J. Biol. Chem., September 30, 2005; 280(39): 33487 - 33496. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. R. Gosmanov, E. Szoke, Z. Israelian, T. Smith, P. E. Cryer, J. E. Gerich, and C. Meyer Role of the Decrement in Intraislet Insulin for the Glucagon Response to Hypoglycemia in Humans Diabetes Care, May 1, 2005; 28(5): 1124 - 1131. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
American Diabetes Association Workgroup on Hypogly Defining and Reporting Hypoglycemia in Diabetes: A report from the American Diabetes Association Workgroup on Hypoglycemia Diabetes Care, May 1, 2005; 28(5): 1245 - 1249. [Full Text] [PDF]
|
|
|
|
|
|
B. Raju and P. E. Cryer Loss of the Decrement in Intraislet Insulin Plausibly Explains Loss of the Glucagon Response to Hypoglycemia in Insulin-Deficient Diabetes: Documentation of the Intraislet Insulin Hypothesis in Humans Diabetes, March 1, 2005; 54(3): 757 - 764. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. A. DeRosa and P. E. Cryer Hypoglycemia and the sympathoadrenal system: neurogenic symptoms are largely the result of sympathetic neural, rather than adrenomedullary, activation Am J Physiol Endocrinol Metab, July 1, 2004; 287(1): E32 - E41. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Zhou, P. O. T. Tran, S. Yang, T. Zhang, E. LeRoy, E. Oseid, and R. P. Robertson Regulation of {alpha}-Cell Function by the {beta}-Cell During Hypoglycemia in Wistar Rats: the "Switch-off" Hypothesis Diabetes, June 1, 2004; 53(6): 1482 - 1487. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. M. Hope, P. O. T. Tran, H. Zhou, E. Oseid, E. Leroy, and R. P. Robertson Regulation of {alpha}-Cell Function by the {beta}-Cell in Isolated Human and Rat Islets Deprived of Glucose: the "Switch-off" Hypothesis Diabetes, June 1, 2004; 53(6): 1488 - 1495. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. E. Cryer Diverse Causes of Hypoglycemia-Associated Autonomic Failure in Diabetes N. Engl. J. Med., May 27, 2004; 350(22): 2272 - 2279. [Full Text] [PDF]
|
|
|
|
|
|
B. Raju, V. P. McGregor, and P. E. Cryer Cortisol Elevations Comparable to Those That Occur During Hypoglycemia Do Not Cause Hypoglycemia-Associated Autonomic Failure Diabetes, August 1, 2003; 52(8): 2083 - 2089. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. P. Robertson, D. E.R. Sutherland, E. R. Seaquist, and K. J. Lanz Glucagon, Catecholamine, and Symptom Responses to Hypoglycemia in Living Donors of Pancreas Segments Diabetes, July 1, 2003; 52(7): 1689 - 1694. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. E. Cryer, S. N. Davis, and H. Shamoon Hypoglycemia in Diabetes Diabetes Care, June 1, 2003; 26(6): 1902 - 1912. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. J. Woerle, C. Meyer, E. M. Popa, P. E. Cryer, and J. E. Gerich Renal Compensation for Impaired Hepatic Glucose Release During Hypoglycemia in Type 2 Diabetes: Further Evidence for Hepatorenal Reciprocity Diabetes, June 1, 2003; 52(6): 1386 - 1392. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Banarer and P. E. Cryer Sleep-Related Hypoglycemia-Associated Autonomic Failure in Type 1 Diabetes: Reduced Awakening From Sleep During Hypoglycemia Diabetes, May 1, 2003; 52(5): 1195 - 1203. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Chico, P. Vidal-Rios, M. Subira, and A. Novials The Continuous Glucose Monitoring System Is Useful for Detecting Unrecognized Hypoglycemias in Patients With Type 1 and Type 2 Diabetes but Is Not Better Than Frequent Capillary Glucose Measurements for Improving Metabolic Control Diabetes Care, April 1, 2003; 26(4): 1153 - 1157. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. J. McCrimmon, M. L. Evans, R. J. Jacob, X. Fan, Y. Zhu, G. I. Shulman, and R. S. Sherwin AICAR and phlorizin reverse the hypoglycemia-specific defect in glucagon secretion in the diabetic BB rat Am J Physiol Endocrinol Metab, November 1, 2002; 283(5): E1076 - E1083. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Diabetes | Diabetes Care | Clinical Diabetes | Diabetes Spectrum |